NYSE:CLVT Clarivate (CLVT) Stock Price, News & Analysis $7.02 +0.12 (+1.74%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$6.87▼$7.0950-Day Range$5.32▼$7.0252-Week Range$5.19▼$9.66Volume4.32 million shsAverage Volume4.29 million shsMarket Capitalization$4.69 billionP/E RatioN/ADividend YieldN/APrice Target$7.78 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Clarivate alerts: Email Address Clarivate MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside10.8% Upside$7.78 Price TargetShort InterestBearish6.93% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.53Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth9.68%From $0.62 to $0.68 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.74 out of 5 starsComputer And Technology Sector481st out of 612 stocksData Processing & Preparation Industry39th out of 58 stocks 2.0 Analyst's Opinion Consensus RatingClarivate has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 3 buy ratings, 3 hold ratings, and 3 sell ratings.Amount of Analyst CoverageClarivate has only been the subject of 1 research reports in the past 90 days.Read more about Clarivate's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted6.93% of the float of Clarivate has been sold short.Short Interest Ratio / Days to CoverClarivate has a short interest ratio ("days to cover") of 6.5.Change versus previous monthShort interest in Clarivate has recently decreased by 3.65%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldClarivate does not currently pay a dividend.Dividend GrowthClarivate does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CLVT. Previous Next 3.1 News and Social Media Coverage News SentimentClarivate has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Clarivate this week, compared to 4 articles on an average week.Search Interest4 people have searched for CLVT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.MarketBeat Follows15 people have added Clarivate to their MarketBeat watchlist in the last 30 days. This is an increase of 1,400% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Clarivate insiders have not sold or bought any company stock.Percentage Held by Insiders22.77% of the stock of Clarivate is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions85.72% of the stock of Clarivate is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Clarivate's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Clarivate are expected to grow by 9.68% in the coming year, from $0.62 to $0.68 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Clarivate is -4.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Clarivate is -4.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioClarivate has a PEG Ratio of 4.53. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioClarivate has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Clarivate's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Clarivate Stock (NYSE:CLVT)Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.Read More CLVT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CLVT Stock News HeadlinesJuly 3, 2024 | marketbeat.comClarivate: The Cheapest AI Stock Worth Buying?Clarivate NYSE: CLVT may not be the cheapest AI stock worth buying, but it is inexpensive and set up to rebound strongly over the next few quarters. Trading at a mere 7.5x its earnings outlook for 2025, it is a super-deep value compared to leading AI plays, and the estimates for earnings growth underestimate the company's potential.July 3, 2024 | marketbeat.comClarivate: The Cheapest AI Stock Worth Buying?Clarivate is deeply undervalued relative to its earnings potential and is set up for a stock price reversal and rally the Q2 results could catalyze.July 26, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.July 24 at 10:35 PM | finanznachrichten.deClarivate Plc: Clarivate Director Richard Roedel to Retire from Board of DirectorsJuly 24 at 7:30 AM | prnewswire.comClarivate Director Richard Roedel to Retire from Board of DirectorsJuly 22, 2024 | msn.comClarivate Plc: Clarivate Acquires Rowan TELS to Enhance Support for Patent PractitionersJuly 22, 2024 | prnewswire.comClarivate Acquires Rowan TELS to Enhance Support for Patent PractitionersJuly 19, 2024 | finanznachrichten.deClarivate Plc: Clarivate to Partner with OhioLINK and SearchOhio to Create a New Unified Library Experience Across the State of OhioJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 19, 2024 | finance.yahoo.comClarivate Plc's (NYSE:CLVT) Intrinsic Value Is Potentially 96% Above Its Share PriceJuly 18, 2024 | prnewswire.comBioWorld by Clarivate Celebrates Nine Wins at 2024 APEX AwardsJuly 18, 2024 | prnewswire.comClarivate to Partner with OhioLINK and SearchOhio to Create a New Unified Library Experience Across the State of OhioJuly 16, 2024 | prnewswire.comClarivate to Report Second Quarter 2024 Results on August 6, 2024July 16, 2024 | prnewswire.comClarivate Annual G20 Scorecard Examines Global Research and Innovation Trends Across G20 MembersJuly 10, 2024 | prnewswire.comClarivate Reveals First Year of Unitary Patent Court Litigation ActivityJuly 2, 2024 | prnewswire.comClarivate Identifies Six Breakthrough MedTech Trends in 2024 Set to Unlock New Industry OpportunitiesJune 27, 2024 | prnewswire.comClarivate Report Demonstrates Societal Impact of Digital Health Research and Innovation GrowthJune 26, 2024 | insidermonkey.comClarivate Plc (CLVT): The Best AI Stock to Buy Under $10?See More Headlines Receive CLVT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Clarivate and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/08/2024Today7/26/2024Next Earnings (Confirmed)8/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Data processing & preparation Sub-IndustryBusiness Services Current SymbolNYSE:CLVT CUSIPN/A CIK1764046 Webwww.clarivate.com Phone442074334000FaxN/AEmployees11,600Year FoundedN/APrice Target and Rating Average Stock Price Target$7.78 High Stock Price Target$10.00 Low Stock Price Target$6.00 Potential Upside/Downside+11.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage9 Analysts Profitability EPS (Most Recent Fiscal Year)($1.66) Trailing P/E RatioN/A Forward P/E Ratio11.21 P/E Growth4.53Net Income$-911,200,000.00 Net Margins-39.29% Pretax Margin-40.15% Return on Equity10.11% Return on Assets3.85% Debt Debt-to-Equity Ratio1.03 Current Ratio0.86 Quick Ratio0.86 Sales & Book Value Annual Sales$2.63 billion Price / Sales1.77 Cash Flow$1.89 per share Price / Cash Flow3.68 Book Value$6.93 per share Price / Book1.00Miscellaneous Outstanding Shares668,240,000Free Float516,080,000Market Cap$4.64 billion OptionableOptionable Beta1.15 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Jonathan Gear (Age 53)CEO & Director Comp: $1.9MMr. Jonathan M. Collins (Age 44)Executive VP & CFO Comp: $1.31MMr. Gordon Samson (Age 58)President of Intellectual Property Comp: $1.08MMr. Bar Veinstein (Age 51)President of Academia & Government Comp: $1.1MMr. Henry Levy (Age 51)President of Life Sciences & Healthcare Comp: $1.05MMr. Michael Easton (Age 51)Senior VP of Finance & Chief Accounting Officer Mr. William E. GraffExecutive VP & Chief Information OfficerMr. Mark J. DonohueHead of Investor RelationsMs. Melanie D. Margolin J.D. (Age 52)Chief Legal Officer & Secretary Ms. Tabita AnderssonSenior Vice President of Communications & BrandMore ExecutivesKey CompetitorsToastNYSE:TOSTRedditNYSE:RDDTGlobantNYSE:GLOBMarathon DigitalNASDAQ:MARABilibiliNASDAQ:BILIView All CompetitorsInstitutional OwnershipBank of New York Mellon CorpSold 1,061,594 shares on 7/26/2024Ownership: 0.335%Raymond James Trust N.A.Bought 37,543 shares on 7/25/2024Ownership: 0.034%Nisa Investment Advisors LLCBought 4,500 shares on 7/20/2024Ownership: 0.001%Raymond James & AssociatesBought 1,157,976 shares on 7/19/2024Ownership: 1.084%Cove Street Capital LLCBought 740,574 shares on 7/18/2024Ownership: 0.111%View All Institutional Transactions CLVT Stock Analysis - Frequently Asked Questions How have CLVT shares performed this year? Clarivate's stock was trading at $9.26 at the start of the year. Since then, CLVT stock has decreased by 24.2% and is now trading at $7.02. View the best growth stocks for 2024 here. How were Clarivate's earnings last quarter? Clarivate Plc (NYSE:CLVT) released its earnings results on Wednesday, May, 8th. The company reported $0.12 earnings per share for the quarter, topping the consensus estimate of $0.10 by $0.02. The business had revenue of $621.20 million for the quarter, compared to analysts' expectations of $614.57 million. Clarivate had a negative net margin of 39.29% and a positive trailing twelve-month return on equity of 10.11%. Who are Clarivate's major shareholders? Top institutional investors of Clarivate include Raymond James & Associates (1.08%), Bank of New York Mellon Corp (0.34%), Cove Street Capital LLC (0.11%) and SG Americas Securities LLC (0.04%). Insiders that own company stock include James Gordon Samson, Andrew Miles Snyder and Mukhtar Ahmed. View institutional ownership trends. How do I buy shares of Clarivate? Shares of CLVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CLVT) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clarivate Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Clarivate With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
